Adam M. Masin

Adam handles complex medical-related litigation for Connecticut’s world-renowned university-affiliated health care system.  His experience includes litigations involving drugs, devices, nutritional supplements, probiotics, neonatology, cardiology, oncology, urogynecology, orthopedics, mycology, hematology, neuropsychology, internal medicine, primary care and a range of other medical specialties. Adam serves on the Board of Directors of the NEC Society, the leading 501(c)(3) dedicated to the neonatal disease necrotizing enterocolitis

Adam has handled appeals in the Second Circuit and Sixth Circuit, and appeared in numerous federal and state courts. He served as judicial intern for U.S. Magistrate Hon. Arlene R. Lindsay in the Eastern District of New York.

Experience

• Obtained complete defense victory as trial counsel for Yale New Haven Hospital in a product liability lawsuit involving the use of probiotics to prevent necrotizing enterocolitis.
• Prepared expert medical witnesses for deposition and trial testimony in the Hip Implant Products MDL.
• Handled all case-specific discovery in one of four MDL Bellwether trial cases for a female pelvic mesh manufacturer. Adam has handled case-specific discovery in dozens of individual pelvic mesh lawsuits.
• Obtained a favorable eight-figure settlement on behalf of an international pharmaceutical manufacturer in a commercial litigation involving the U.S. marketing of their branded drug.
• Obtained complete trial court and Second Circuit victories in Megna v. Food and Drug Administration, a product liability lawsuit involving Interferon.
• Obtained complete trial court and Sixth Circuit victories in a diet drug lawsuit, Montgomery v. Wyeth, based on the Tennessee statute of repose, and successfully defended a collateral attack on the judgment in the MDL Court.
• Obtained complete trial court and appellate victories in Nelson v. Wyeth, the first hormone therapy case to go to trial in the Philadelphia Court of Common Pleas.
• Obtained complete trial court and appellate victories in Cochran v. Wyeth, setting Pennsylvania precedent that a failure to warn claim cannot be based on injuries the plaintiff did not have.
• Briefed Wyeth’s summary judgment motion in Bailey v. Wyeth, which held Wyeth’s hormone therapy warnings to be adequate as a matter of New Jersey law and resulted in dismissal of hundreds of cases.